Table 2 Comparison of clinical outcomes in COVID-19 patients included in the Philippine CORONA Study stratified by coronary artery disease or heart failure diagnoses

(n = 512)

(n = 10,369)

All-cause mortality

< 0.001

Mortality, n (%)

153 (29.88%)

1549 (14.94%)

Survivor, n (%)

359 (70.12%)

8820 (85.06%)

Death from cardiac cause^a

45 (29.41%)

213 (13.75%)

< 0.001

Non-cardiac causes of mortality

Acute respiratory distress syndrome, n (%)

58 (37.91%)

662 (42.74%)

0.249

Septic shock, n (%)

55 (35.95%)

632 (40.80%)

0.243

Brain herniation, n (%)

7 (4.58%)

59 (3.81%)

0.640

Multiorgan dysfunction, n (%)s

23 (15.03%)

120 (7.75%)

0.002

Others, n (%)

16 (3.12%)

180 (1.74%)

0.021

Neurologic outcomes^b

< 0.001

Full/partial improvement, n (%)

96 (74.42%)

1543 (86.88%)

Stable, no improvement, n (%)

33 (25.58%)

233 (13.12%)

Respiratory failure, n (%)

169 (75.7%)

1439 (13.88%)

< 0.001

Admitted to ICU, n (%)

Length of ICU stay in days^c, median (IQR)

15 (11)

15 (12)

0.670

Length of hospital stay in days, median (IQR)

14 (11)

13 (9)

< 0.001